Celon Pharma S.A. (CLN)
Market Open
12 Jun, 14:50
WSE 
zł
21. 10
+0.05
+0.2375%
zł
- Market Cap
- P/E Ratio
- Div Yield
6,178 Volume
- Eps
zł 21.05
Previous Close Want to track CLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Celon Pharma S.A. (CLN) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.18B
Trailing P/E (ttm) 10.32
Forward P/E -
PEG ratio -0.37
Price/Sales (ttm) 5.17
Price/Book (mrq) 2.12
Enterprise Value/Revenue 5.38
Enterprise Value/EBITDA -1,406.79
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13.61K
Average volume (90 days) 9K
Price summary
52-Week low 18.5
52-Week high 25.3
Beta -
50-Day moving average 21
200-Day moving average 21.15
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.49%
Operating margin -0.12%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.14
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.17
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 1.2%
Book value per share (mrq) 10.33
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
